Antony Odell

Antony Odell is a seasoned executive with extensive experience in the medical and biotechnology sectors. Since November 2018, Antony Odell has served as Chief Executive Officer at Echopoint Medical Ltd and concurrently holds the position of Executive Chair at TANDEM NANO LTD. As a Director at NorthInvest since May 2018, Antony Odell continues to contribute to investment and growth in the industry. Previous roles include CEO at Tissue Regenix Group plc from October 2008 to October 2017 and CEO at Tayside Flow Technologies Ltd from January 2003 to September 2007. Antony Odell has also held significant positions such as VP Medical at BTG and International Knee Manager at Stryker. Educational credentials include a BSc (Hons) in Physiology & Biochemistry from the University of Southampton, obtained from 1979 to 1982.